Xin-yuan Liu

State Key Laboratory Of Cell Biology, 320 Yueyang Road
Xuhui, 200031, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Correction to: Identification of TAZ as the essential molecular switch in orchestrating SCLC phenotypic transition and metastasis.

Correction to: Identification of TAZ as the essential molecular switch in orchestrating SCLC phenotypic transition and metastasis.

Journal: National science review

Published: December 29, 2023

Double-modified oncolytic adenovirus armed with a recombinant interferon-like gene enhanced abscopal effects against malignant glioma.

Double-modified oncolytic adenovirus armed with a recombinant interferon-like gene enhanced abscopal effects against malignant glioma.

Journal: Neuro-oncology advances

Published: October 16, 2023

Potent antitumor efficacy of human dental pulp stem cells armed with YSCH-01 oncolytic adenovirus.

Potent antitumor efficacy of human dental pulp stem cells armed with YSCH-01 oncolytic adenovirus.

Journal: Journal of translational medicine

Published: July 16, 2023

Identification of TAZ as the essential molecular switch in orchestrating SCLC phenotypic transition and metastasis.

Identification of TAZ as the essential molecular switch in orchestrating SCLC phenotypic transition and metastasis.

Journal: National science review

Published: June 23, 2021

Optimization of the Administration Strategy for the Armed Oncolytic Adenovirus ZD55-IL-24 in Both Immunocompromised and Immunocompetent Mouse Models.

Optimization of the Administration Strategy for the Armed Oncolytic Adenovirus ZD55-IL-24 in Both Immunocompromised and Immunocompetent Mouse Models.

Journal: Human gene therapy

Published: June 22, 2021

Combined oncolytic adenovirus carrying MnSOD and mK5 genes both regulated by survivin promoter has a synergistic inhibitory effect on gastric cancer.

Combined oncolytic adenovirus carrying MnSOD and mK5 genes both regulated by survivin promoter has a synergistic inhibitory effect on gastric cancer.

Journal: Neoplasma

Published: May 08, 2021

Enhanced anti-melanoma efficacy through a combination of the armed oncolytic adenovirus ZD55-IL-24 and immune checkpoint blockade in B16-bearing immunocompetent mouse model.

Enhanced anti-melanoma efficacy through a combination of the armed oncolytic adenovirus ZD55-IL-24 and immune checkpoint blockade in B16-bearing immunocompetent mouse model.

Journal: Cancer immunology, immunotherapy : CII

Published: August 31, 2020

The armed oncolytic adenovirus ZD55-IL-24 eradicates melanoma by turning the tumor cells from the self-state into the nonself-state besides direct killing.

The armed oncolytic adenovirus ZD55-IL-24 eradicates melanoma by turning the tumor cells from the self-state into the nonself-state besides direct killing.

Journal: Cell death & disease

Published: August 05, 2020

Mechanism and therapeutic prospect of resveratrol combined with TRAIL in the treatment of renal cell carcinoma.

Mechanism and therapeutic prospect of resveratrol combined with TRAIL in the treatment of renal cell carcinoma.

Journal: Cancer gene therapy

Published: August 27, 2019

Inhibition of kinesin family member 20B sensitizes hepatocellular carcinoma cell to microtubule-targeting agents by blocking cytokinesis.

Inhibition of kinesin family member 20B sensitizes hepatocellular carcinoma cell to microtubule-targeting agents by blocking cytokinesis.

Journal: Cancer science

Published: May 15, 2018

Fighting Cancer with Viruses: Oncolytic Virus Therapy in China.

Fighting Cancer with Viruses: Oncolytic Virus Therapy in China.

Journal: Human gene therapy

Published: December 30, 2017

Reducing protein regulator of cytokinesis 1 as a prospective therapy for hepatocellular carcinoma.

Reducing protein regulator of cytokinesis 1 as a prospective therapy for hepatocellular carcinoma.

Journal: Cell death & disease

Published: December 14, 2017

Showing 1-12 of 36

Last Updated: 09/26/2026